Jo-Anne R. Dillon

Jo-Anne R. Dillon, FRSC, FCAHS

Distinguished Professor, Department of Biochemistry, Microbiology and Immunology, and Research Scientist, Vaccine and Infectious Disease Organization — International Vaccine Centre, University of Saskatchewan (Saskatoon, SK)

February 2, 2018

Dr. Dillon received a B.Sc. from the University of Toronto and a M.Sc. and PhD in Microbiology and Immunology from Queen’s University. She completed postdoctoral research studies in the Department of Biophysics and Microbiology, at the University of Pittsburgh, where she first began research on Neisseria gonorrhoeae.

Dr. Dillon has held the following positions: Chief, Antimicrobials and Molecular Biology Division, Laboratory Centre for Disease Control, Health Canada; founding Chief, National Laboratory for Sexually Transmitted Diseases, Health Canada; Adjunct Professor, Department of Biology, University of Ottawa; Chair, Department of Microbiology and Immunology and Interim Chair, Department of Biochemistry, Microbiology and Immunology, College of Medicine, University of Ottawa; Inaugural Director, Centre for Research in Biopharmaceuticals and Biotechnology, University of Ottawa; and Dean, College of Arts and Science, University of Saskatchewan. She is currently Head, Department of Microbiology and Immunology (College of Medicine) and Research Scientist at the Vaccine and Infectious Disease Organization at the University of Saskatchewan.

She leads the World Health Organization (WHO) endorsed Gonococcal Antimicrobial Surveillance Program (GASP) in Latin America and the Caribbean. She has led several national and international organizations and has consulted widely on STIs and public health with national and international institutions. Dr. Dillon has been awarded distinguished career awards by the Canadian Society of Microbiologists and the American Sexually Transmitted Diseases Association. She is a Fellow of the Royal Society of Canada and the Canadian Academy of Health Sciences.


Role: Panel Member
Report: When Antibiotics Fail (November 2019)